Michael Pellini
Director/Board Member at SINGULAR GENOMICS SYSTEMS, INC.
Net worth: 200 787 $ as of 2024-04-29
Profile
Mike is a Managing Partner of S32, a venture capital fund investing at the frontiers of technology and healthcare.
Prior to joining S32 in 2017, he served as CEO of Foundation Medicine, a company which transformed the way pharmaceutical companies and physicians evaluate the genomic changes underlying a patient’s cancer, until he transitioned to Chairman through the close of Roche’s (RHHBY) acquisition of FMI in August 2018.
Previously, he was President and COO of Clarient, a national leader in molecular pathology, which was acquired by GE Healthcare in 2010.
He currently serves as a member of the Board of Directors for Nusano, Singular Genomics (OMIC), Adaptive Biotechnologies (ADPT), Octave BioSciences, TwinStrand Genomics, the Personalized Medicine Coalition, and the American Cancer Society.
He previously served on the board of Thrive Earlier Detection, which was acquired by Exact Sciences (EXACT) in 2021, and Tango Therapeutics (TNGX).
Mike brings a breadth of understanding in personalized medicine, with a particular interest and focus on defeating cancer.
He is also a member of the President’s Leadership Council at Thomas Jefferson University and Jefferson Health.
During the COVID pandemic, Mike served as a Senior Advisor to the Rockefeller Foundation’s efforts on COVID-19 testing.
Mike received a BA from Boston College, an MBA from Drexel University and an MD from Jefferson Medical College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-28 | 351,222 ( 0.47% ) | 140 840 $ | 2024-04-29 | |
2024-03-31 | 22,968 ( 0.02% ) | 59 946 $ | 2024-04-29 |
Michael Pellini active positions
Companies | Position | Start |
---|---|---|
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Board Member | 2018-02-12 |
SINGULAR GENOMICS SYSTEMS, INC. | Director/Board Member | 2017-03-31 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Private Equity Investor | 2017-11-30 |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Director/Board Member | 2022-12-31 |
Octave Health Group, Inc.
Octave Health Group, Inc. Medical/Nursing ServicesHealth Services Octave Health Group, Inc. provides therapy services. It offers coaching and classes and group sessions related to anxiety, depression, chronic insomnia, bipolar disorder, trauma, chronic pain, personality perfectionism, anger management, relationships, intimacy, work stress, parenthood, and related general issues. The company was founded by Kristen Scarlett, Sarah Gundle, and Sandeep Acharya and is headquartered in New York, NY. | Director/Board Member | - |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Director/Board Member | - |
Go2 Foundation For Lung Cancer | Director/Board Member | - |
Nusano, Inc.
Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022. | Director/Board Member | - |
Cradle Genomics, Inc.
Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Cradle Genomics, Inc. engages in researching and developing life sciences. The company was founded by Randy Armant, Richard Shippy and Sascha Drewlo and is headquartered in San Diego, CA. | Director/Board Member | - |
░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Michael Pellini
Companies | Position | End |
---|---|---|
░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Michael Pellini
Drexel University | Masters Business Admin |
Boston College | Undergraduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
SAFEGUARD SCIENTIFICS, INC. | Finance |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
GENEDX HOLDINGS CORP. | Health Services |
Private companies | 23 |
---|---|
Clarient, Inc.
Clarient, Inc. Medical/Nursing ServicesHealth Services Clarient, Inc. provides cancer diagnostic testing services. It offers oncology diagnostic testing services to community pathologists, oncologists, biopharmaceutical companies, and researchers. The company was founded in 1993 and is headquartered in Aliso Viejo, CA. | Health Services |
Acelerate, Inc.
Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Genomics Collaborative, Inc.
Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Commercial Services |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
PLUS Diagnostics, Inc.
PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ. | Health Services |
Mission Hospital Foundation | |
Cira Discovery Sciences, Inc.
Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Cira Discovery Sciences, Inc. creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from '-omics' methodologies represents an opportunity to create value for Life Sciences enterprises. It applies these methods: in close collaboration with scientists in the pharmaceutical and biotechnology industries to facilitate the discovery of safe and potent new medicines and in the development of more accurate and sensitive diagnostic tests for disease and drug response. The company was incorporated in 2003, by happy chance on the 50th anniversary of the publication of Watson and Crick's famous paper on the double-helical structure of DNA. | Commercial Services |
Coriell Institute for Medical Research
Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services The Coriell Institute for Medical Research provides research support services to enhance biobanking and distribution initiatives. The private company is based in Camden, NJ. The company offers expert assistance, resources, and solutions to accelerate scientific research goals. The company provides laboratory services such as stem cell R & D, custom lab services, kitting, organoids, iPSC reprogramming, and genomic and epigenomic services. | Commercial Services |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Commercial Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA. | Health Services |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Health Services |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Finance |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Health Technology |
Cradle Genomics, Inc.
Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Cradle Genomics, Inc. engages in researching and developing life sciences. The company was founded by Randy Armant, Richard Shippy and Sascha Drewlo and is headquartered in San Diego, CA. | Commercial Services |
Octave Health Group, Inc.
Octave Health Group, Inc. Medical/Nursing ServicesHealth Services Octave Health Group, Inc. provides therapy services. It offers coaching and classes and group sessions related to anxiety, depression, chronic insomnia, bipolar disorder, trauma, chronic pain, personality perfectionism, anger management, relationships, intimacy, work stress, parenthood, and related general issues. The company was founded by Kristen Scarlett, Sarah Gundle, and Sandeep Acharya and is headquartered in New York, NY. | Health Services |
Nusano, Inc.
Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022. | Health Technology |
Go2 Foundation For Lung Cancer | |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Michael Pellini